Linking private and public to improve drug discovery
23 February 2010
Ian Schofield
Please Login to read the full article.
23 February 2010
Ian Schofield
For some years now the pharmaceutical industry has been adapting its strategies to address the challenges posed by cost-containment, patent expiries and the decline in R&D productivity.
As cost and other pressures increase, companies have outsourced activities such as preclinical...
Please Login to read the full article.
RELATED CONTENT
NEWS
- IMI plans "unprecedented" programme for novel antibiotics as drug resistance continues to rise
- US Capitol Capsule: Obama gives tech transfer some love
- Industry and EC seek public-private route to new antimicrobials
- UK govt offers "step change" in support for regenerative medicine
COMMENT
Other Informa Comment
FEATURES
- DKSH highlights one-stop benefits as it builds Asia market expansion services
- Merck BioVentures: where biosimilars make a difference
EVENTS
Today
London
28 February 2012
Pestana Chelsea Bridge Hotel London
04 March 2012
The Marriott World Center, Orlando, Florida
JOB OF THE WEEK
Promote your vacancy here
